SCHEMBL4905936

SCHEMBL4905936

COC(=O)c1cc(S(=O)(=O)NCCSc2nc3ccccc3s2)ccc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.54
MAPT P10636 4/20 0.54
LMNA P02545 4/20 0.54
CYP2C9 P11712 2/20 0.51
GAA P10253 2/20 0.51
CYP3A4 P08684 1/20 0.51
ALOX5 P09917 5/20 0.50
HTT P42858 1/20 0.49
CYP2C19 P33261 2/20 0.47
CYP2D6 P10635 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ALDH1A1 P00352 4/20 0.47
TSHR P16473 2/20 0.47
MAPK1 P28482 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HSD17B10 Q99714 2/20 0.47
POLB P06746 2/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906166 0.91 MAPT (0.55) SMN1; SMN2MAPTLMNACYP2C9GAA
SCHEMBL4904118 0.91 SMN1; SMN2 (0.52) SMN1; SMN2MAPTLMNACYP2C9GAA
SCHEMBL4905743 0.88 ALOX5 (0.54) SMN1; SMN2MAPTLMNACYP2C9GAA
SCHEMBL4908596 0.86 MAPT (0.70) SMN1; SMN2MAPTLMNAGAAALOX5
SCHEMBL4902624 0.83 SMN1; SMN2 (0.53) SMN1; SMN2MAPTLMNAGAAHTT
SCHEMBL4900787 0.83 MAPT (0.54) SMN1; SMN2MAPTLMNACYP2C9GAA
SCHEMBL4902435 0.81 TSHR (0.49) SMN1; SMN2MAPTLMNAALDH1A1TSHR
SCHEMBL4904264 0.80 ALOX5 (0.55) SMN1; SMN2MAPTLMNAGAAALOX5
SCHEMBL4902792 0.79 ALOX5 (0.52) SMN1; SMN2MAPTLMNACYP2C9GAA
SCHEMBL4903629 0.79 MAPT (0.73) SMN1; SMN2MAPTLMNAGAAALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD SMN1; SMN2 3404/4885MAPT 1786/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD SMN1; SMN2 3404/4885MAPT 1786/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.